Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 11 matches for

The COG trial results are published online today - this was a randomised controlled trial to compare gefitinib with placebo in previously treated patients with advanced oesophageal cancer.

MANTIS

Botnar Hip

Managing Avascular Necrosis Treatments : An Interventional Study

WHITE-5

Botnar Hip

FAIT

Botnar Hip

FAIT is a multicentre randomised controlled clinical trial comparing surgical and non-surgical approaches to treating femoroacetabular impingement (hip impingement).

WHITE-4

Botnar Hip

World Hip Trauma Evaluation Four

Glyn-Jones Group | Hip Research Group

Botnar Hip

Our research focuses on hip osteoarthritis, from identifying its causes to developing new surgery techniques for the condition.

Find out more about

Our Groups, Centres and Units

Our Research Themes

Our Clinical Trials

Our Programme Grants

Similar stories

FRUITI Trial is given OCTRU Green Light approval

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.

International Clinical Trials Day

Researchers across the world celebrate International Clinical Trials Day today. We have produced a short animation this year to mark the occasion...

Clinical trial finds Azithromycin has no benefit against COVID-19

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.